| Literature DB >> 26895679 |
Kamraan Madhani1, James J Farrell2.
Abstract
There is an evolving understanding that autoimmune pancreatitis (AIP) is an immunoglobulin (Ig) G4 systemic disease. It can manifest as primarily a pancreatic disorder or in association with other disorders of presumed autoimmune cause. Classic clinical characteristics include obstructive jaundice, abdominal pain, and acute pancreatitis. Thus, AIP can be difficult to distinguish from pancreatic malignancy. However, AIP may respond to therapy with corticosteroids, and has a strong association with other immune mediated diseases. Although primarily a pathologic diagnosis, attempts have been made to reliably diagnose AIP clinically. AIP can be classified as either type 1 or type 2.Entities:
Keywords: Autoimmune pancreatitis; Corticosteroids; Idiopathic duct-centric pancreatitis; IgG4; International Consensus Diagnostic Criteria; Lymphoplasmacytic sclerosing pancreatitis
Mesh:
Substances:
Year: 2016 PMID: 26895679 DOI: 10.1016/j.gtc.2015.10.005
Source DB: PubMed Journal: Gastroenterol Clin North Am ISSN: 0889-8553 Impact factor: 3.806